Q3 2018 13F Holders as of 9/30/2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
22.2M
-
Number of holders
-
150
-
Total 13F shares, excl. options
-
8.57M
-
Shares change
-
+519K
-
Total reported value, excl. options
-
$1.83B
-
Value change
-
+$67M
-
Put/Call ratio
-
0.25
-
Number of buys
-
93
-
Number of sells
-
-68
-
Price
-
$214.13
Significant Holders of MADRIGAL PHARMACEUTICALS, INC. - Common Stock (MDGL) as of Q3 2018
194 filings reported holding MDGL - MADRIGAL PHARMACEUTICALS, INC. - Common Stock as of Q3 2018.
MADRIGAL PHARMACEUTICALS, INC. - Common Stock (MDGL) has 150 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 8.57M shares
of 22.2M outstanding shares and own 38.59% of the company stock.
Largest 10 shareholders include Capital Research Global Investors (1.66M shares), BAKER BROS. ADVISORS LP (1.17M shares), Vanguard Group Inc (706K shares), BlackRock Inc. (575K shares), PRICE T ROWE ASSOCIATES INC /MD/ (501K shares), venBio Select Advisor LLC (463K shares), STATE STREET CORP (428K shares), Rock Springs Capital Management LP (342K shares), HealthCor Management, L.P. (263K shares), and JENNISON ASSOCIATES LLC (223K shares).
This table shows the top 150 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.